Strata Skin Scien (SSKN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,412 | -3,790 | -4,033 | -21,514 | -3,335 |
| Depreciation Amortization | 3,911 | 4,995 | 5,554 | 7,468 | 9,039 |
| Income taxes - deferred | 254 | -111 | -303 | 55 | 240 |
| Accounts receivable | 1,352 | -1,036 | -222 | 184 | 558 |
| Other Working Capital | 596 | -133 | 214 | 1,250 | -583 |
| Other Operating Activity | 395 | 2,304 | 1,686 | 16,697 | -5,597 |
| Operating Cash Flow | $2,096 | $2,229 | $2,896 | $4,140 | $322 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,159 | -115 | -13 | -320 | N/A |
| Net Acquisitions | N/A | N/A | N/A | N/A | 125 |
| Other Investing Activity | 0 | -2,676 | -1,772 | -1,874 | -993 |
| Investing Cash Flow | $-2,159 | $-2,791 | $-1,785 | $-2,194 | $-868 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -357 | N/A | N/A |
| Debt Issued | 2,528 | 7,275 | N/A | N/A | 1,500 |
| Debt Repayment | N/A | -7,571 | -3,000 | -1,429 | N/A |
| Common Stock Issued | 18 | 0 | 17,000 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -2,336 | -374 | -333 |
| Financing Cash Flow | $2,546 | $-296 | $11,307 | $-1,803 | $1,167 |
| Exchange Rate Effect | N/A | N/A | N/A | -2 | 4 |
| Beginning Cash Position | 15,629 | 16,487 | 4,069 | 3,928 | 3,303 |
| End Cash Position | 18,112 | 15,629 | 16,487 | 4,069 | 3,928 |
| Net Cash Flow | $2,483 | $-858 | $12,418 | $141 | $625 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,096 | 2,229 | 2,896 | 4,140 | 322 |
| Capital Expenditure | -2,159 | -115 | -13 | -320 | N/A |
| Free Cash Flow | -63 | 2,114 | 2,883 | 3,820 | 322 |